Literature DB >> 12454205

Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase.

Hwa C Lee1, Manoj K Patel, Dilawaar J Mistry, Qingcai Wang, Sita Reddy, J Randall Moorman, J Paul Mounsey.   

Abstract

DMPK is a serine/threonine kinase implicated in the human disease myotonic muscular dystrophy (DM). Skeletal muscle Na channels exhibit late reopenings in Dmpk-deficient mice and peak current density is reduced, implicating DMPK in regulation of membrane excitability. Since complete heart block and sudden cardiac death occur in the disease, we tested the hypothesis that cardiac Na channels also exhibit abnormal gating in Dmpk-deficient mice. We made whole cell and cell-attached patch clamp recordings of ventricular cardiomyocytes enzymatically isolated from wild-type, Dmpk+/-, and Dmpk-/- mice. Recordings from membrane patches containing one or a few Na channels revealed multiple Na channel reopenings occurring after the macroscopic Na current had subsided in both Dmpk+/- and Dmpk-/- muscle, but only rare reopenings in wild-type muscle (>3-fold difference, P < 0.05). This resulted in a plateau of non-inactivating Na current in Dmpk-deficient muscle. The magnitude of this plateau current was independent on the magnitude of the test potential from -40 to 0 mV and was also independent of gene dose. Macroscopic Na current density was similar in wild-type and Dmpk-deficient muscle, as was steady-state Na channel gating. Decay of macroscopic currents was slowed in Dmpk-/- muscle, but not in Dmpk+/- or wild-type muscle. Entry into, and recovery from, inactivation were similar at multiple test potentials in wild-type and Dmpk-deficient muscle. Resting membrane potential was depolarized, and action potential duration was significantly prolonged in Dmpk-deficient muscle. Thus in cardiac muscle, Dmpk deficiency results in multiple late reopenings of Na channels similar to those seen in Dmpk-deficient skeletal muscle. This is reflected in a plateau of non-inactivating macroscopic Na current and prolongation of cardiac action potentials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12454205     DOI: 10.1152/physiolgenomics.00095.2002

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  5 in total

Review 1.  RNAi: a potential new class of therapeutic for human genetic disease.

Authors:  Attila A Seyhan
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

2.  Sodium current properties of primary skeletal myocytes and cardiomyocytes derived from different mouse strains.

Authors:  M Mille; X Koenig; E Zebedin; P Uhrin; R Cervenka; H Todt; K Hilber
Journal:  Pflugers Arch       Date:  2008-08-13       Impact factor: 3.657

3.  In vivo assessment of muscle membrane properties in myotonic dystrophy.

Authors:  S Veronica Tan; Werner J Z'graggen; Delphine Boërio; Christopher Turner; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2016-05-24       Impact factor: 3.217

4.  Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy.

Authors:  Chung-Chuan Chou; Po-Cheng Chang; Yi-Chia Wei; Kuang-Yung Lee
Journal:  J Am Heart Assoc       Date:  2017-04-17       Impact factor: 5.501

5.  Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.

Authors:  Yanlin Wang; Lei Hao; Hongcai Wang; Katherine Santostefano; Arjun Thapa; John Cleary; Hui Li; Xiuming Guo; Naohiro Terada; Tetsuo Ashizawa; Guangbin Xia
Journal:  Mol Ther       Date:  2018-09-11       Impact factor: 11.454

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.